Management of Skin Malignancies, points to know and learn

Written By :  Dr. Nandita Mohan
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-08-22 04:00 GMT   |   Update On 2022-08-22 04:00 GMT
Advertisement

The prognosis of skin cancers in India is worse when compared to the Western countries. It may be because of overall rarity and low experience at individual centers, presentation with advanced disease, inadequate first treatment and a higher incidence of poor prognostic disease subtypes.

To analyze the clinicopathological characteristics, recurrence Management of Skin Malignancies, points to know and learn patterns and the completeness of first treatment in the patients with skin cancers a study was conducted and published in Journal of Postgraduate Medicine, Education and Research.

A retrospective analysis of all patients operated for skin cancers was done. There were 18 cases of skin malignancies of which 44.4% patients had Multiple Myeloma 27.8% had Squamous cell carcinoma, 11.1% had Basal cell carcinoma and dermatofibrosarcoma and 5.6% had Merkel cell carcinoma. Pain was the most common presenting symptom.

The median delay between the primary treatment and definitive surgery was 8 months which led to an increase in surgical morbidity.

Therefore, the authors concluded that skin cancers have poor outcomes in Indian patients when compared to the Western countries. Hence, awareness programs for early diagnosis, a high index of suspicion and early referral to a center experienced in handling these malignancies may help in improving outcomes.

Reference: Abhinav Singh, Siddhant Khare et al Management of Skin Malignancies: Lessons Learnt at a Tertiary Care Center in Northern India; Journal of Postgraduate Medicine, Education and Research, Volume Issue: 56, DOI:10.5005/jp-journals-10028-1567.

Full View
Tags:    
Article Source : Postgraduate Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News